John Paulson’s portfolio: Paulson & Co 13F holdings
Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026
Q3 2023 filing in brief
In its Q3 2023 13F, filed November 14, 2023, Paulson & Co reported $1.1B across 18 US positions. The largest: HORIZON THERAPEUTICS PUB L (21.8%), BHC (19.4%), AAMI (15.5%), NG (7.6%), PPTA (7.2%). In the quarter it opened 1 position, sold out of 4, added to 2 and trimmed 0; positions opened and sold out came to 15.1% of the portfolio's value.
Methodology
Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.
Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.
Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.
Holdings
Filed Nov 14, 2023
- 1 New
- 2 Added
- 0 Trimmed
- 4 Exited
18 positions at September 30, 2023. Q/Q change compares shares with the preceding quarter.
| Row | Ticker | Issuer | Status | ||||
|---|---|---|---|---|---|---|---|
| 1 | — | HORIZON THERAPEUTICS PUB L | $243M | 2.1M | 21.77% | +320.6% | Added |
| 2 | BHC | BAUSCH HEALTH COS INC | $217M | 26.4M | 19.45% | 0.0% | Held |
| 3 | AAMI | BRIGHTSPHERE INVT GROUP INC | $174M | 9.0M | 15.53% | 0.0% | Held |
| 4 | NG | NOVAGOLD RES INC | $85M | 22.2M | 7.64% | 0.0% | Held |
| 5 | PPTA | PERPETUA RESOURCES CORP | $81M | 24.8M | 7.23% | 0.0% | Held |
| 6 | MDGL | MADRIGAL PHARMACEUTICALS INC | $73M | 500.0K | 6.53% | +42.8% | Added |
| 7 | — | ANGLOGOLD ASHANTI PLC | $61M | 3.8M | 5.42% | — | New |
| 8 | THRY | THRYV HLDGS INC | $38M | 2.0M | 3.36% | 0.0% | Held |
| 9 | AEM | AGNICO EAGLE MINES LTD | $36M | 783.6K | 3.19% | 0.0% | Held |
| 10 | SSRM | SSR MINING IN | $27M | 2.0M | 2.38% | 0.0% | Held |
| 11 | SA | SEABRIDGE GOLD INC | $22M | 2.1M | 1.95% | 0.0% | Held |
| 12 | THM | INTERNATIONAL TOWER HILL MIN | $22M | 61.9M | 1.95% | 0.0% | Held |
| 13 | EQX | EQUINOX GOLD CORP | $11M | 2.5M | 0.95% | 0.0% | Held |
| 14 | NMRK | NEWMARK GROUP INC | $8M | 1.3M | 0.74% | 0.0% | Held |
| 15 | TMQ | TRILOGY METALS INC NEW | $7M | 14.3M | 0.63% | 0.0% | Held |
| 16 | TELLEUR | TELLURIAN INC NEW | $6M | 5.3M | 0.55% | 0.0% | Held |
| 17 | BABA | ALIBABA GROUP HLDG LTD | $4M | 50.0K | 0.39% | 0.0% | Held |
| 18 | IAG | IAMGOLD CORP | $4M | 1.9M | 0.36% | 0.0% | Held |
4 exited positions
Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.
| Ticker | Issuer | Previous value | Previous shares |
|---|---|---|---|
| AU3EUR | ANGLOGOLD ASHANTI LIMITED | $81M | 3.8M |
| NEM | NEWMONT CORP | $19M | 452.0K |
| OPHTEUR | IVERIC BIO INC | $984K | 25.0K |
| — | DIVERSEY HLDGS LTD | $420K | 50.0K |
Every quarter on file (53)
From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.